Logo Unión Europea

Olanzapine Impurity B (EP)

GA01138 - 98%

In stock
Delivery: 3 to 5 working days
Others quantities on request


  • Description


    Olanzapine (originally branded Zyprexa) is an atypical antipsychotic. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder. It is structurally similar to clozapine and quetiapine. It is a dopamine antagonist and is classified as a thienobenzodiazepine.

    We have successfully synthesized impurities of the Olanzapine. This will be of interest to pharmaceutical companies and analytical labs.

  • Additional information
    Packing Unit

    100 mg, 50 mg